268 related articles for article (PubMed ID: 18469364)
1. Detection of IgE anti-parvovirus antibodies in human breast milk.
Smith-Norowitz TA; Drew H; Norowitz HM; Nowakowski M; Bluth EF; Durkin HG; Bluth MH
Ann Clin Lab Sci; 2008; 38(2):168-73. PubMed ID: 18469364
[TBL] [Abstract][Full Text] [Related]
2. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Durkin HG; Smith-Norowitz TA
Hum Immunol; 2005 Oct; 66(10):1029-38. PubMed ID: 16386644
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
4. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Josephson AS; Durkin HG; Smith-Norowitz TA
Clin Immunol; 2003 Aug; 108(2):152-8. PubMed ID: 12921761
[TBL] [Abstract][Full Text] [Related]
5. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
6. Immunologic aspects of breast feeding, antiinfectious activity of breast milk.
Butler JE
Semin Perinatol; 1979 Jul; 3(3):255-70. PubMed ID: 392768
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
8. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
9. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
Oliveira SA; Camacho LA; Pereira AC; Faillace TF; Setubal S; Nascimento JP
Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):965-70. PubMed ID: 12471422
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
[TBL] [Abstract][Full Text] [Related]
11. Recurrent erythema in patients with long-term parvovirus B19 infection.
Musiani M; Manaresi E; Gallinella G; Cricca M; Zerbini M
Clin Infect Dis; 2005 Jun; 40(12):e117-9. PubMed ID: 15909254
[TBL] [Abstract][Full Text] [Related]
12. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.
Navalpotro D; Gimeno C; Navarro D
J Med Virol; 2006 Nov; 78(11):1449-51. PubMed ID: 16998885
[TBL] [Abstract][Full Text] [Related]
13. Detection of specific IgG antibody production in vivo in infants with congenital HIV, parvovirus B19 or Toxoplasma gondii infection.
Gerritsen EJ; Dijkstra NH; Van Elsacker-Niele AM; Salimans MM; Goudsmit J; Boer K; Van Knapen F; Stegagno M; Cohen BJ; Rotmans JP
Immunodeficiency; 1993; 4(1-4):145-8. PubMed ID: 8167690
[No Abstract] [Full Text] [Related]
14. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
16. Presumed parvovirus B19-associated retinal pigment epitheliopathy.
Grand MG; Storch GA
Retina; 2000; 20(2):199-202. PubMed ID: 10783955
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
18. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.
Ferguson M; Walker D; Cohen B
Biologicals; 1997 Sep; 25(3):283-8. PubMed ID: 9324996
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.
Matsuda H; Sakaguchi K; Shibasaki T; Takahashi H; Kawakami Y; Furuya K
J Perinat Med; 2005; 33(6):561-3. PubMed ID: 16318623
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to parvovirus B19 NS-1 protein in infected individuals.
von Poblotzki A; Gigler A; Lang B; Wolf H; Modrow S
J Gen Virol; 1995 Mar; 76 ( Pt 3)():519-27. PubMed ID: 7534811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
